Domrol Oral Drops
Marketer
Xenial Pharma
Salt Composition
Domperidone (10mg)
Overview Domrol Oral Drops
Gastric relief is provided by GastroSolve Oral Drops, indicated for indigestion, nausea, and vomiting. It accelerates gastrointestinal transit, alleviating bloating, satiety, and stomach upset. Administer GastroSolve Oral Drops thirty minutes prior to meals, following your physician's prescribed dosage and duration. Dosage is individualized based on your health status and response. Continue treatment as directed by your doctor. Disclose all other medications to your doctor, as interactions are possible. Common, typically transient, side effects include headache, xerostomia, and abdominal pain. Report any concerning side effects immediately. Dizziness may also occur; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential side effect exacerbation. Diarrhea is a possibility; increased fluid intake is recommended to prevent dehydration. Inform your physician of any liver or kidney conditions before starting treatment. Concurrent antacid use should be avoided. Pregnant individuals should consult their doctor. This medication is contraindicated in patients with active peptic ulcers.
Primary Ingredients of Domrol Oral Drops
No text was provided to rewrite.
Uses of Domrol Oral Drops
Managing indigestion, nausea, and vomiting.
Major Benefits of Domrol Oral Drops:
Administer this medication precisely as your physician prescribes, adhering to both the dosage and treatment length. Always consult the product label for detailed instructions prior to use. Accurate measurement should be achieved using the provided calibrated dropper. Domrol Oral Drops are to be ingested on an empty stomach.
Common Side effects of Domrol Oral Drops:
- Headache
- Dryness in mouth
- Stomach pain
- Diarrhea
How to use Domrol Oral Drops:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to use. Utilize the provided calibrated dropper for accurate measurement and ingestion. Consume Domrol Oral Drops on an empty stomach.
How Domrol Oral Drops works:
Domrol Oral Drops stimulate gastrointestinal motility. Their action centers on the brain's emetic control center, suppressing nausea and vomiting. Simultaneously, they enhance upper gastrointestinal tract peristalsis, facilitating the efficient passage of food through the stomach.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Domrol Oral Drops may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Domrol Oral Drops during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Lactating mothers can generally use Domrol Oral Drops without concern. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Domrol Oral Drops might reduce awareness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Domrol Oral Drops with care, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Domrol Oral Drops to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before use. Domrol Oral Drops are contraindicated in patients exhibiting moderate to severe liver dysfunction.
What if you forget to take Domrol Oral Drops :
Should you forget a dose of Domrol Oral Drops, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Domrol Oral Drops
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Action Class | Prokinetic agent with dopamine (D2) receptor antagonism |



